Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke

NCT01948739 · The University of Texas Health Science Center, Houston · Updated 29 June 2021

What is being tested
MAHI EXO-II exoskeleton augmented with BMI system
For
Stroke; Hemiparesis
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 75 years. About 18 people. The full rules are on the registry page.
Where
United States
When
Starts or started 24 Sept 2013, ends 28 April 2018. Registered 24 Sept 2013.
Results
Posted on the registry on 29 June 2021.

In the researchers' words

The purpose of this study is: 1. To augment the MAHI Exo-II, a physical human exoskeleton, with a non-invasive brain machine interface (BMI) to actively include patient in the control loop and thereby making the therapy 'active'. 2. To determine appropriate robotic (kinematic data acquired through sensors on robotic device ) and electrophysiological ( electroencephalography- EEG based) measures of arm motor impairment and recovery after stroke. 3. To demonstrate that the BMI controlled MAHI Exo-II robotic arm training is feasible and effective in improving arm motor functions in sub-acute and chronic stroke population.
ClinicalTrials.gov, NCT01948739

Sites

  • The Institute for Rehabilitation and Research (TIRR) at Memorial HermannHouston, Texas, United States